- Home
- UFPT vs IMCR Comparison
UFPT vs IMCR Comparison
Compare UFPT & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFPT
- IMCR
- Stock Information
- Founded
- UFPT 1963
- IMCR 2008
- Country
- UFPT United States
- IMCR United Kingdom
- Employees
- UFPT N/A
- IMCR N/A
- Industry
- UFPT Medical/Dental Instruments
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UFPT Health Care
- IMCR Health Care
- Exchange
- UFPT Nasdaq
- IMCR Nasdaq
- Market Cap
- UFPT 1.7B
- IMCR 1.8B
- IPO Year
- UFPT 1993
- IMCR 2021
- Fundamental
- Price
- UFPT $219.54
- IMCR $32.88
- Analyst Decision
- UFPT Buy
- IMCR Buy
- Analyst Count
- UFPT 2
- IMCR 10
- Target Price
- UFPT $289.00
- IMCR $58.13
- AVG Volume (30 Days)
- UFPT 115.3K
- IMCR 325.8K
- Earning Date
- UFPT 08-04-2025
- IMCR 08-07-2025
- Dividend Yield
- UFPT N/A
- IMCR N/A
- EPS Growth
- UFPT 34.62
- IMCR N/A
- EPS
- UFPT 8.62
- IMCR N/A
- Revenue
- UFPT $588,559,000.00
- IMCR $356,145,000.00
- Revenue This Year
- UFPT $22.16
- IMCR $27.43
- Revenue Next Year
- UFPT $5.60
- IMCR $8.64
- P/E Ratio
- UFPT $25.48
- IMCR N/A
- Revenue Growth
- UFPT 40.98
- IMCR 26.78
- 52 Week Low
- UFPT $178.26
- IMCR $23.15
- 52 Week High
- UFPT $366.41
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- UFPT 45.02
- IMCR 46.01
- Support Level
- UFPT $196.83
- IMCR $31.02
- Resistance Level
- UFPT $230.02
- IMCR $33.73
- Average True Range (ATR)
- UFPT 12.74
- IMCR 1.54
- MACD
- UFPT -0.18
- IMCR -0.05
- Stochastic Oscillator
- UFPT 36.01
- IMCR 36.73
About UFPT UFP Technologies Inc.
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.